"Our hospital is home to the Essentia Health St. Mary’s-Heart & Vascular Center. Anesthesiology, Bariatric Surgery, Birthing Center, Cardiothoracic Surgery, Colorectal Surgery, CT Scan, Critical Care, Dietitian, ENT Surgery, Emergency Medicine, Endocrine Surgery, Eye Surgery, General Surgery, Grief Support, Gynecologic Surgery, Heart & Vascular Center, Hospice Care, Hospitalist Services, Imaging & Radiology, Interventional Neurology, Lab Services, MRI, Mental Health, Neurosurgery, Occupational Therapy, Orthopedic Surgery, Physical Therapy, Podiatric Surgery, Psychiatry, Retina Surgery, Speech-Language Therapy, Spiritual Care, Supportive & Palliative Care, Tobacco Cessation, Toxicology, Trauma Surgery, Urologic Surgery, Vascular Surgery"

During the past decade, Essentia Health Saint Mary's Medical Center conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 97 clinical trials were completed, i.e. on average, 90.7% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 46 clinical trials were completed. i.e. 124.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Essentia Health Saint Mary's Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "Alliance for Clinical Trials in Oncology" with 35 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "Children's Oncology Group" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Essentia Health Saint Mary's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Essentia Health Saint Mary's Medical Center" are "Breast Cancer" (14 trials), "Recurrent Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Essentia Health Saint Mary's Medical Center" in a lesser frequency.

Most popular intervention types in "Essentia Health Saint Mary's Medical Center" are "Drug" (218 trials), "Other" (114 trials), "Biological" (106 trials), "Procedure" (53 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Quality-of-Life Assessment" (38 trials), "Paclitaxel" (23 trials), "Carboplatin" (21 trials) and "Computed Tomography" (20 trials). Other intervention names were less common.

The vast majority of trials in "Essentia Health Saint Mary's Medical Center" are 225 trials for "All" genders, 33 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Essentia Health Saint Mary's Medical Center". undefined are not yet recruiting, 39 are recruiting, 71 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 121 completed trials in Essentia Health Saint Mary's Medical Center, 5 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Essentia Health Saint Mary's Medical Center, 15 "Phase 1" clinical trials were conducted, 112 "Phase 2" clinical trials and 130 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".